Tandem Diabetes Care says FDA clears Mobi as first tubeless AID system with up to 7 days of wear
TNDM•Tandem Diabetes Care said the FDA cleared its Tandem Mobi as the world's first tubeless automated insulin delivery system with up to seven days of wear. A full U.S. commercial launch of the tubeless cartridge and infusion set is planned for the first half of 2027.
1. FDA clearance
Tandem Diabetes Care said the FDA cleared Tandem Mobi as the world's first tubeless automated insulin delivery system with up to seven days of wear. The company plans a full U.S. commercial launch of its tubeless cartridge and infusion set in the first half of 2027.
